Short answer
Zimmer Biomet (ZBH) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). $1.0B total debt issuance completed November 12, 2026, expanding Zimmer Biomet’s financing capacity.
Zimmer Biomet 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $1.0B total debt issuance completed November 12, 2026, expanding Zimmer Biomet’s financing capacity
- €500.0M notes at 4.375% due 2033, creating euro-denominated interest and refinancing exposure
- $500.0M notes at 5.850% due 2036, locking in long-term dollar funding at elevated interest cost
- Potential proceeds use for 2026 and 2027 note repayment, which could reduce near-term refinancing needs
- Underwriters or affiliates may hold existing notes, creating potential conflicts in allocating repayment proceeds
Item 2.03 · Creation of a Direct Financial Obligation
- New EUR Notes carry 4.375% annual interest and mature November 12, 2033
- New USD Notes carry 5.850% semiannual interest and mature November 12, 2036
- Long-dated debt increases fixed financing commitments through 2033 and 2036
- Change-of-control repurchase obligation: 101% of principal plus accrued interest
- Issuer call rights begin August 12, 2033 for EUR Notes and August 12, 2036 for USD Notes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zimmer Biomet 8-K filings
Get the next ZBH 8-K as it lands
Follow ZBH for push alerts, or ask the research agent what this filing means.